Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Novartis Ag ADR (NVS)

Novartis Ag ADR (NVS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 202,894,592
  • Shares Outstanding, K 2,236,739
  • Annual Sales, $ 52,877 M
  • Annual Income, $ 24,021 M
  • 60-Month Beta 0.52
  • Price/Sales 3.78
  • Price/Cash Flow 9.92
  • Price/Book 3.24
Trade NVS with:

Options Overview Details

View History
  • Implied Volatility 18.97% ( +0.59%)
  • Historical Volatility 19.74%
  • IV Percentile 66%
  • IV Rank 30.08%
  • IV High 32.40% on 03/08/22
  • IV Low 13.20% on 12/31/21
  • Put/Call Vol Ratio 0.45
  • Today's Volume 1,108
  • Volume Avg (30-Day) 923
  • Put/Call OI Ratio 0.80
  • Today's Open Interest 53,255
  • Open Int (30-Day) 58,067

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate 1.52
  • Number of Estimates 3
  • High Estimate 1.57
  • Low Estimate 1.46
  • Prior Year 1.64
  • Growth Rate Est. (year over year) -7.32%

Price Performance

See More
Period Period Low Period High Performance
1-Month
83.37 +10.27%
on 05/09/22
92.12 -0.21%
on 05/24/22
+2.72 (+3.05%)
since 04/22/22
3-Month
79.09 +16.23%
on 03/08/22
94.26 -2.47%
on 04/11/22
+6.25 (+7.29%)
since 02/24/22
52-Week
79.09 +16.23%
on 03/08/22
95.17 -3.40%
on 08/17/21
+3.91 (+4.44%)
since 05/24/21

Most Recent Stories

More News
Top Analyst Reports for Bank of America, Novo Nordisk, & Novartis

Today's Research Daily features new research reports on 16 major stocks, including Bank of America Corporation (BAC), Novo Nordisk A/S (NVO), and Novartis AG (NVS).

BAC : 35.65 (-0.61%)
NVS : 91.93 (+1.34%)
ADI : 161.85 (+0.19%)
PBR : 14.23 (-12.48%)
NVO : 107.98 (+0.13%)
SONY : 89.03 (-0.82%)
Novartis (NVS) Cosentyx Gets Positive CHMP Opinion for JIA

Novartis (NVS) Cosentyx gets a positive CHMP recommendation for the indication of juvenile idiopathic arthritis.

NVS : 91.93 (+1.34%)
GERN : 1.2700 (unch)
AMGN : 251.89 (+1.14%)
ALKS : 28.35 (-3.24%)
Is Perrigo a Buy After Reporting Q1 Earnings?

The shares of leading baby formula maker Perrigo Company (PRGO) have been soaring in price of late amid a nationwide baby formula shortage. So, because the crisis is expected to continue through the coming...

MRK : 94.64 (+0.86%)
NVO : 107.98 (+0.13%)
NVS : 91.93 (+1.34%)
PRGO : 38.52 (-0.13%)
Alnylam's (ALNY) Marketed Drugs Aid Growth Amid Competition

Alnylam's (ALNY) portfolio of approved drugs is witnessing strong uptake so far while its pipeline is progressing well. However, stiff competition in the target market remains a woe.

ALNY : 127.05 (-1.95%)
NVS : 91.93 (+1.34%)
AGLE : 1.3700 (-8.67%)
APLT : 1.4700 (-2.00%)
Should You Buy This High-Yielding Big Pharma Stock?

Novartis can provide investors with a market-crushing 3.8% dividend yield -- and that isn't all the stock has to offer.

COMP : 5.26 (-8.20%)
NVS : 91.93 (+1.34%)
Teva Pharmaceutical Industries: Why Investors Should Buy the Dip

Shares of Teva Pharmaceutical (TEVA) have plunged in price due to the company’s weak financials and its reduction of its top-line guidance. However, can the stock rebound by the company leveraging its...

MRK : 94.64 (+0.86%)
NVO : 107.98 (+0.13%)
NVS : 91.93 (+1.34%)
TEVA : 8.45 (unch)
2 Dividend Stocks to Boost Your Passive Income

Despite challenging economic conditions, these companies are unlikely to cut their dividends.

NVS : 91.93 (+1.34%)
AAPL : 140.36 (-1.92%)
Got $5,000? Buy and Hold These 3 Dividend Growth Stocks for the Long Haul

If you invest in these stocks, it's likely your dividend income will increase over the years.

NVS : 91.93 (+1.34%)
CL : 78.12 (+2.09%)
FTS : 50.78 (+0.95%)
Worried About a Market Meltdown? Then Buy These 5 Stocks Now

The market’s near-term outlook remains uncertain on concerns over the persistent macroeconomic and geopolitical issues. But we think investors worried about a market meltdown can look to add quality...

FMS : 30.11 (+0.80%)
GIB : 83.11 (-1.54%)
KOF : 57.09 (-0.38%)
NVS : 91.93 (+1.34%)
PHI : 37.33 (-2.20%)
Deciphera (DCPH) Down Despite Narrower-Than-Expected Q1 Loss

Deciphera (DCPH) reports narrower-than-expected loss in the first quarter of 2022 while revenues beat estimates.

NVS : 91.93 (+1.34%)
VRTX : 268.48 (+0.05%)
DCPH : 10.76 (-8.27%)
APLT : 1.4700 (-2.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Novartis has one of the strongest and broadest portfolio of oncology drugs and generics. It continues to build depth in 5 core therapeutic areas Cardio-Renal, Immunology, Neuroscience, Oncology and Hematology, strength in technology platforms - Targeted Protein Degradation, Cell Therapy, Gene Therapy,...

See More

Key Turning Points

3rd Resistance Point 93.54
2nd Resistance Point 92.83
1st Resistance Point 92.38
Last Price 91.93
1st Support Level 91.22
2nd Support Level 90.51
3rd Support Level 90.06

See More

52-Week High 95.17
Last Price 91.93
Fibonacci 61.8% 89.03
Fibonacci 50% 87.13
Fibonacci 38.2% 85.23
52-Week Low 79.09

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar